Brussels start-up Nutrinomics raises 550,000 euros in capital – Companies

Brussels start-up Nutrinomics has raised 550,000 euros in capital for the development of the Zest food platform. The platform provides nutritional advice to cancer patients and the chronically ill. The investors are Mensura, imec.istart and two business angels.

At Brussels Europe Hospitals, the Zest nutrition platform is now recommended for cancer patients as part of their treatment. That partnership is an important milestone for startup Nutrinomics, the nutrition consulting company behind Zest.

Stéphanie Roland launched Nutrinomics in 2020. It happened after she returned from the United States, where she had already tested the financial options for nutritional counseling for cancer patients with Saana. That company provided personal meals at home to cancer patients. Roland returned for personal reasons and started his new venture in nutrition consulting in Belgium. More than 1,000 patients are already using the app.

While Zest includes a shopping list and delivers customized recipes every week, it does not want to profile itself as a shopping service for the chronically ill. “We use algorithms and scientifically available knowledge to make personal nutritional recommendations,” says Stéphanie Roland.

The importance of nutrition

Four out of ten chronically ill patients and up to 80 percent of cancer patients are malnourished. It has an impact on their healing process. For example, malnutrition in cancer patients is the actual cause of death in 10 to 20 percent. Zest recommends a specific diet that is tailored to the treatment processes and based on medical parameters.

“Currently, there is no automatic connection to data from the journal,” says Roland. “We are working on a questionnaire with almost 30 questions to collect the medical information.”

The basis for the advice is strictly scientific, the company emphasizes. It is also seen in the team of eight employees. These are dietitians, engineers and researchers. For the sake of credibility, Nutrinomics is also investing heavily in collaborations such as with Europa Hospitals and MSD Belgium. In addition, it participates in clinical trials to support the scientific basis of the app.

At Brussels Europe Hospitals, the Zest nutrition platform is now recommended for cancer patients as part of their treatment. That partnership is an important milestone for the startup Nutrinomics, the nutrition consulting company behind Zest. Stéphanie Roland launched Nutrinomics in 2020. It happened after she returned from the United States, where she had already tested the financial options for nutritional counseling for cancer patients with Saana. That company provided personal meals at home to cancer patients. Roland returned for personal reasons and started his new venture in nutrition consulting in Belgium. More than 1,000 patients are already using the app. Although Zest includes a shopping list option and provides bespoke recipes every week, it does not want to profile itself as a shopping service for the chronically ill. “We use algorithms and scientifically available knowledge to make personal dietary recommendations,” says Stéphanie Roland. Four out of ten chronically ill patients and up to 80 percent of cancer patients are malnourished. It has an impact on their healing process. For example, malnutrition in cancer patients is the actual cause of death in 10 to 20 percent. Zest recommends a specific diet tailored to the treatment courses and based on medical parameters. “Currently, there is no automatic correlation with data from the medical record,” says Roland. “We are working on a questionnaire with almost 30 questions to collect the medical information.” The basis for the advice is strictly scientific, the company emphasizes. It is also seen in the team of eight employees. These are dietitians, engineers and researchers. For the sake of credibility, Nutrinomics is also investing heavily in collaborations such as with Europa Hospitals and MSD Belgium. In addition, it participates in clinical trials to support the scientific basis of the app.

Leave a Comment